CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 24,781	$ 25,574
General and administrative	7,737	5,988
Total operating expenses	32,518	31,562
Loss from operations	(32,518)	(31,562)
Other income, net	1,997	2,291
Net loss	(30,521)	(29,271)
Other comprehensive income (loss):
Unrealized gain (loss) on marketable securities	(113)	365
Total comprehensive loss	$ (30,634)	$ (28,906)
Net loss per share, basic	$ (0.79)	$ (0.76)
Net loss per share, diluted	$ (0.79)	$ (0.76)
Weighted average number of shares used in computing net loss per share, basic	38,625,365	38,280,539
Weighted average number of shares used in computing net loss per share, diluted	38,625,365	38,280,539